...Read More
The Latest from
-
November 23, 2018
This week the Valens Research team highlights our most interesting equity insight from across our tools and our analysis. While the market may be searching for reasons for pessimism, management’s focus on maintaining ROA’ and confidence about growth mean market expectations are too negative and the company is undervalued...
Read More -
November 23, 2018
...Read More
-
November 22, 2018
Highlighted Top Ideas
CYH – Community Health Systems, Inc.
LB – L Brands, Inc.
MTW – The Manitowoc Company, Inc.Other Recent Analyses
AMAG – AMAG Pharmaceuticals, Inc.
Read More
RPM – RPM International Inc.... -
November 21, 2018
In the middle of a retest is the hardest, and best, time to trust the (right) data
Tell me if you’ve heard this before:
“Any time the market falls 6%+ in 2 days, investors justifiably ask whether something has changed that should impact their investment thesis. This is when a consistent framework like the Market Phase Cycle is most valuable.”...
Read More -
November 21, 2018
Thermo Fisher Scientific Inc. (TMO:USA)currently trades near historical highs relative to UAFRS-based (Uniform) Earnings, with a 20.1x Uniform P/E. However, even at these levels, the market has bearish expectations for the firm, and management has concerns about revenue guidance, service line and pharma services growth, and their outlook for FY 2019...
Read More -
November 21, 2018
Each week the Valens Securities team highlights our most interesting insights from across our tools and our analysis, including individual company industry and macro insights Top Highlight: Honeywell International Inc. Other Highlights: FDS, GOOGL, OR:FRA Other Recent Analyses: AGN, BBBY, CC, CHK, CRUS, CVI, DAL, DHR, HCA, IBM, PYPL, SHW, TMO, TXN...
Read More -
November 20, 2018
Gilead Sciences, Inc. (GILD:USA)trades well below corporate averages relative to UAFRS-based (Uniform) Earnings, with a 9.6x Uniform P/E. At these levels, the market is pricing in bearish expectations for the firm, and while management has concerns about their HIV portfolio, guidance, and pricing in Europe, a strong development pipeline and overall business strength support long-term outperformance and equity upside if GILD is able to maintain current profitability levels...
Read More -
November 19, 2018
Chesapeake Energy Corporation (CHK:USA)currently trades at historical lows relative to UAFRS-based (Uniform) Assets, with a 0.2x Uniform P/B, implying bearish expectations for the firm. However, management is confident about their WildHorse asset acquisition, their focus on expanding margins, and their transportation portfolio...
Read More -
November 19, 2018
Each week, Valens focuses on several companies that were analyzed in the prior week, where material distortions caused by as-reported GAAP accounting need to be corrected to understand a company’s economic fundamentals. This week, we focus on TripAdvisor, Inc. (TRIP), G-III Apparel Group, Ltd. (GIII), LogMeIn, Inc. (LOGM)...
Read More -
November 16, 2018
The Chemours Company (CC:USA)currently trades well below corporate averages relative to UAFRS-based (Uniform) Earnings, with an 8.8x Uniform P/E, implying bearish expectations for the firm, and management may have concerns about margin expansion of Fluoroproducts, Opteon, and their Mining Solutions facility...
Read More -
November 16, 2018
This week the Valens Research team highlights our most interesting equity insight from across our tools and our analysis. Cirrus appears to be making the right calls with strong management alignment, favorable fundamentals, smart strategic decisions, and growing management optimism, pointing to equity upside...
Read More -
November 15, 2018
Highlighted Top Ideas
CCI – Crown Castle International Corp.
DAL – Delta Air Lines, Inc.
NAV – Navistar International CorporationOther Recent Analyses
ESV – Ensco plc
Read More
R – Ryder System, Inc....